Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKazera Global Regulatory News (KZG)

Share Price Information for Kazera Global (KZG)

Share Price is delayed by 15 minutes
Get Live Data
1.025    -0.025 (-2.38%)
Bid:
1.00
Ask:
1.05
Spread: 0.05 (5.00%)
Market Cap: £11.31m
KZG Live PriceLast checked at - London Stock Exchange

Intraday Kazera Global Share Chart

Director Share Purchase

9 Sep 2024 13:30

RNS Number : 4638D
Kazera Global PLC
09 September 2024
 

9 September 2024

 

Kazera Global plc ("Kazera" or "the Company")

Director Share Purchase

 

Kazera Global plc, the AIM-quoted investment company, has been notified that Dennis Edmonds, CEO of Kazera, purchased a further 2,450,000 ordinary shares of 0.1p each in the Company ("Ordinary Shares") at a price of 1.20 pence per share on 9 September 2024.

 

Following the share purchase, Dennis Edmonds' beneficial interest in the Company is 16,496,137 Ordinary Shares, representing 1.76 % of the Company's issued share capital.

 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Dennis Edmonds

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Kazera Global plc

b)

Legal Entity Identifier

213800U4PZ148SFLGY26

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of 0.1 pence each

 

 

 

 

 

 

GB00B830HW33

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Currency

GBP

d)

Price(s) and volume(s)

Price(s)

Volume(s)

1.20p

2,450,000

 

e)

Aggregated information

- Aggregated volume

- Price

- Aggregated total

2,450,000 Ordinary Shares, bought at a price of 1.20 pence per share, totalling £29,400

f)

Date of the transaction

9 September 2024

g)

Place of the transaction

London Stock Exchange, AIM

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the company's obligations under Article 17 of MAR.

 

ENDS

 

For further information visit www.kazeraglobal.com or contact: 

 

Kazera Global plc

Dennis Edmonds, CEO

 

 

kazera@stbridespartners.co.uk

Cavendish Capital Markets Ltd (Nominated Adviser and Broker)

Derrick Lee / Pearl Kellie (Corporate Finance)

Tel: +44 (0)207 220 0500

St Brides Partners(Financial PR)

Paul Dulieu/Isabel de Salis

kazera@stbridespartners.co.uk

 

 

About Kazera Globalplc

Kazera is a global investment company focused on leveraging the skills and expertise of its Board of Directors to develop early-stage mineral exploration and development assets towards meaningful cashflow and production. Its three principal investments are as follows:

 

Alluvial diamond mining through Deep Blue Minerals (Pty) Ltd, Alexander Bay, South Africa

Kazera currently has a 100% direct interest in Deep Blue Minerals, of which 74% is held beneficially by Kazera and 26% is held on behalf of Black Economic Empowerment partners.

 

Heavy Mineral Sands mining (including ilmenite, monazite, rutile, and zircon) through Whale Head Minerals (Pty) Ltd, Alexander Bay, South Africa.

Kazera currently has a 70% direct beneficial interest in Whale Head Minerals together with the benefit of a loan facility entitling it to receive approximately £38m out of dividends from the other shareholders.

 

Tantalite mining in South-East Namibia (divestment in progress)

As announced on 20 December 2022, Kazera has agreed to dispose of African Tantalum (Pty) Ltd ("Aftan") for a cash consideration of US$13 million plus a debenture payment of 2.5% of the gross sales of produced lithium and tantalum for life-of-mine. Completion of the sale is subject to receipt of full consideration proceeds. Aftan has been deconsolidated from the Company's financial statements with effect from 4 January 2023 because in accordance with the terms of the sale agreement, it has relinquished control of the Aftan in favour of the purchaser, Hebei Xinjian Construction Close Corp ("Hebei Xinjian") with effect from that date. Kazera retains the right to cancel the transaction and retain all amounts paid to date in the event of default by Hebei Xinjian.

 

The Company will consider additional investment opportunities as appropriate, having regard to the Group's future cash flow requirements.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHLLMTTMTTMBFI
Date   Source Headline
1st Dec 20097:00 amRNSAcquisition
22nd Sep 200912:28 pmRNSAnnual Financial Report
29th Jul 200912:14 pmRNSAnnual General Meeting
16th Jun 20097:00 amRNSPreliminary Results
3rd Mar 20093:50 pmRNSHolding(s) in Company
3rd Mar 20092:40 pmRNSHolding(s) in Company
2nd Mar 20095:11 pmRNSHolding(s) in Company
2nd Mar 20094:00 pmRNSHolding(s) in Company
2nd Mar 20098:05 amRNSDirector/PDMR Shareholding
26th Feb 20092:02 pmRNSResult of General Meeting
10th Feb 20094:35 pmRNSPrice Monitoring Extension
10th Feb 20097:00 amRNSIssue of Equity
19th Nov 20087:01 amRNSInterim Results
29th Oct 20087:01 amRNSTrading Statement
10th Oct 20084:52 pmRNSSecond Price Monitoring Extn
10th Oct 20084:41 pmRNSPrice Monitoring Extension
7th Oct 20089:39 amRNSHolding(s) in Company
25th Sep 20089:52 amRNSAnnual Report and Accounts
10th Sep 20085:36 pmRNSHolding(s) in Company
1st Sep 20087:30 amRNSDirectorate Change
18th Aug 20083:00 pmRNSDisposal of investment proper
30th Jul 20082:39 pmRNSDirector/PDMR Shareholding
30th Jul 200810:59 amRNSQ1 Update and Result of EGM
10th Jul 200811:45 amRNSDirector/PDMR Shareholding
8th Jul 20089:17 amRNSNotice of EGM
30th Jun 20083:02 pmRNSDirectorate Change
19th Jun 20087:00 amRNSPreliminary Results
29th Apr 20084:54 pmRNSChange of registered address
15th Apr 20082:06 pmRNSWebsite Address
14th Apr 20084:00 pmRNSChange of name effective
14th Apr 20082:03 pmRNSResult of AGM/Change of name
7th Apr 20082:54 pmRNSDirector/PDMR Shareholding
7th Apr 200812:45 pmRNSDirector/PDMR Shareholding
12th Mar 20088:00 amRNSDirector/PDMR Shareholding
11th Mar 200811:37 amRNSDirector/PDMR Shareholding
11th Mar 20087:02 amRNSFinal Results
1st Feb 200812:14 pmRNSHolding(s) in Company
1st Feb 20087:00 amRNSTrading Statement
16th Jan 200812:22 pmRNSHolding(s) in Company
10th Dec 20077:00 amRNSRestoration
7th Dec 20075:01 pmRNSTrading Statement
6th Dec 200711:45 amRNSResult of EGM
3rd Dec 20077:30 amRNSStatement re. Suspension
3rd Dec 20077:30 amRNSSuspension - Worthington Nich
22nd Nov 20077:01 amRNSDirectorate & Adviser Change
9th Nov 20077:01 amRNSNotice of EGM
2nd Nov 200711:33 amRNSIssue of Equity
2nd Nov 20077:01 amRNSIssue of Equity
29th Oct 20077:01 amRNSRequisition Update
24th Oct 20072:59 pmRNSNotice of Requisition of EGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.